FibroBiologics Inc. Commo...

NASDAQ: FBLG · Real-Time Price · USD
0.57
-0.02 (-3.06%)
At close: Aug 15, 2025, 3:59 PM
0.57
-1.21%
After-hours: Aug 15, 2025, 05:55 PM EDT

FibroBiologics Common Stock Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
573K 437K 94K n/a
Gross Profit
-573K -437K -94K n/a
Operating Income
-13.74M -8.89M -4.47M -1.58M
Interest Income
251K n/a n/a n/a
Pretax Income
-11.16M -16.48M -5.12M -1.58M
Net Income
-11.16M -16.48M -5.12M -1.58M
Selling & General & Admin
9.23M 6.52M 3.23M 1.06M
Research & Development
4.5M 2.37M 1.15M 521K
Other Expenses
n/a n/a n/a n/a
Operating Expenses
13.74M 8.89M 4.37M 1.58M
Interest Expense
20K 147K 654K 4K
Selling & Marketing Expenses
n/a 685K -94K n/a
Cost & Expenses
-13.74M 8.89M 4.47M 1.58M
Income Tax Expense
n/a n/a n/a n/a
Shares Outstanding (Basic)
32.88M 32.49M 32.49M 32.49M
Shares Outstanding (Diluted)
32.88M 28.23M 32.49M 32.49M
EPS (Basic)
-0.34 -0.59 -0.16 -0.05
EPS (Diluted)
-0.34 -0.68 -0.16 -0.05
EBITDA
-13.74M -15.9M -4.37M -1.58M
EBIT
-11.18M -16.34M -4.47M -1.58M
Depreciation & Amortization
573K 437K 94K n/a